On March 6, 2020, the President signed into law the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123). This act provides funding to prevent, prepare for, and respond to Coronavirus Disease 2019 (COVID-19).
To support governmental public health emergency response to COVID-19, the Centers for Disease Control and Prevention (CDC) has activated CDC-RFA-TP18-1802 Cooperative Agreement for Emergency Response: Public Health Crisis Response. CDC is awarding funding, totaling $569,822,380, under Components A and B to the 65 eligible jurisdictions that are on the approved but unfunded (ABU) list for CDC-RFA-TP18-1802 to provide resources to prevent, prepare for, and respond to COVID-19.
This funding is intended for state, local, territorial, and tribal health departments to carry out surveillance, epidemiology, laboratory capacity, infection control, mitigation, communications, and other preparedness and response activities. These funds are in addition to funds CDC previously awarded on March 4 to select jurisdictions for COVID-19 response activities.
For more information on the COVID-19 supplemental funding, please see the COVID-19 Crisis Response Cooperative Agreement – Components A and B Supplemental Funding Interim Guidancepdf icon.
- CDC COVID-19 Crisis Response Total Funding to Date (Epidemiology and Laboratory Capacity (ELC) & Crisis Cooperative Agreement) external icon
- Information on Coronavirus Disease 2019 Supplemental Funding to Jurisdictionspdf icon
- CDC COVID-19 Crisis Response Funding Webinar, March 18, 2020pdf icon
- CDC COVID-19 Website
- CDC Newsroom